Canaccord Genuity Maintains Buy on WAVE Life Sciences, Raises Price Target to $52

Wave Life Sciences Ltd. -2.51%

Wave Life Sciences Ltd.

WVE

7.39

-2.51%

Canaccord Genuity analyst Whitney Ijem maintains WAVE Life Sciences (NASDAQ: WVE) with a Buy and raises the price target from $43 to $52.